Asahi Kasei Pharma Venture Capital

Founded in 2018, Asahi Kasei Pharma Venture Capital is a venture fund investing in biopharmaceutical companies. The firm makes global investments but primarily invests in North American and European companies.

Asahi Kasei Pharma VC invests in private early-stage biotechnology companies with an interest in companies that are developing therapeutics for immunology, inflammation, kidney disease, neurodegenerative disease, and rare diseases. The firm also invests in technology companies developing platforms to support drug discovery, drug delivery systems, and cell therapies.